Literature DB >> 8843739

IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments.

B A Booth1, M Boes, R S Bar.   

Abstract

Insulin-like growth factor binding protein (IGFBP)-3 was exposed to plasmin, thrombin, and pregnancy serum, substances normally present at the endothelial surface in enriched concentrations. The NH2-termini of the proteolytic fragments were sequenced, and their ability to bind insulin-like growth factor (IGF) and heparin was assessed by ligand blotting. Plasmin generated at least five fragments, three beginning at the NH2-terminus of IGFBP-3 and two with NH2-termini corresponding to middle portions of IGFBP-3. The dominant fragment bound both IGF and heparin while NH2-terminal fragments bound only IGF. Thrombin generated three and serum five easily identified fragments; the dominant fragments, beginning at midportions of IGFBP-3, retained IGF and heparin affinity, whereas the remaining fragments had differential affinities for IGF and heparin. We suggest that such fragments, when generated at the endothelia surface, have the potential to alter regional vascular concentrations of IGF and thus influence both IGF and endothelial function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843739     DOI: 10.1152/ajpendo.1996.271.3.E465

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Damage control mechanisms in articular cartilage: the role of the insulin-like growth factor I axis.

Authors:  J A Martin; M B Scherb; L A Lembke; J A Buckwalter
Journal:  Iowa Orthop J       Date:  2000

2.  A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation.

Authors:  S Selvarajan; L R Lund; T Takeuchi; C S Craik; Z Werb
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

Review 3.  Implications of the PAPP-A-IGFBP-IGF-1 pathway in the pathogenesis and treatment of polycystic kidney disease.

Authors:  Sonu Kashyap; Julianna D Zeidler; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Cell Signal       Date:  2020-06-20       Impact factor: 4.315

4.  Open surgery induces a dramatic decrease in circulating intact IGFBP-3 in patients with colorectal cancer not seen with laparoscopic surgery.

Authors:  I Kirman; V Cekic; N Poltoratskaia; P Sylla; S Jain; K A Forde; R L Whelan
Journal:  Surg Endosc       Date:  2004-11-11       Impact factor: 4.584

5.  Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia.

Authors:  Audrey M Thiebaut; Izaskun Buendia; Vanessa Ginet; Eloise Lemarchand; Mehdi Boutagouga Boudjadja; Yannick Hommet; Laurent Lebouvier; Charlotte Lechevallier; Mike Maillasson; Elodie Hedou; Nicole Déglon; Franck Oury; Marina Rubio; Joan Montaner; Julien Puyal; Denis Vivien; Benoit D Roussel
Journal:  Autophagy       Date:  2021-09-14       Impact factor: 13.391

6.  Interaction of insulin-like growth factor binding protein-3 with latent transforming growth factor-beta binding protein-1.

Authors:  Yaoting Gui; Liam J Murphy
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

Review 7.  Insulin-like growth factor system in cancer: novel targeted therapies.

Authors:  Varsha P Brahmkhatri; Chinmayi Prasanna; Hanudatta S Atreya
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

8.  Structural basis for assembly and disassembly of the IGF/IGFBP/ALS ternary complex.

Authors:  Hyojin Kim; Yaoyao Fu; Ho Jeong Hong; Seong-Gyu Lee; Dong Sun Lee; Ho Min Kim
Journal:  Nat Commun       Date:  2022-07-30       Impact factor: 17.694

9.  Multiple Growth Factor Targeting by Engineered Insulin-like Growth Factor Binding Protein-3 Augments EGF Receptor Tyrosine Kinase Inhibitor Efficacy.

Authors:  Elizabeth A Wang; Wan-Yu Chen; Chi-Huey Wong
Journal:  Sci Rep       Date:  2020-02-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.